Artwork
iconShare
 
Manage episode 386929773 series 2874357
Content provided by The Bioverge Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bioverge Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Andrew Lo, Professor of Finance, and the Director of the Laboratory for Financial Engineering at the MIT Sloan School of Management, sits down with Neil to discuss his application of portfolio theory to address the challenges of funding drug development and how a Netflix subscription model can address the coming crisis in funding high-priced curative therapies approaching the market.
  continue reading

43 episodes